Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “AMINOBUTYRIC ACID”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,639 records · Page 91Linked to original sources

Autoradiographic localization of gamma-aminobutyric acid receptors in the rat central nervous system by using [3H]muscimol.

Muscimol, a structural analogue and potent agonist of gamma-aminobutyric acid (GABA), was used in its tritiated form for the autoradiographic localization of GABA receptors in the rat central nervous system. [(3)H]Muscimol ([(3)H]M) was incubated with brain slices or was injected intracortically or into intraocular brain transplants. As indicated by [(3)H]M binding and autoradiographic silver grains, GABA receptors display a laminar distribution over the cerebellar cortex, cerebral cortex, and hippocampus (in order of decreasing quantity); and a nonlaminar distribution in the caudate nucleus and substantia nigra. [(3)H]M binding was not affected by brief prior treatment of brain slices with (-)nipecotic acid or guvacine, two potent inhibitors of GABA uptake, indicating receptor binding specificity. Systemic administration of unlabeled muscimol interferred with binding of [(3)H]M binding subsequently administered in vitro, indicating that muscimol or a metabolite of it traverses the blood/brain barrier and binds to receptor sites, possibly in a manner competitive with [(3)H]M. [(3)H]M binding was greatest in the cerebellum. Quantitative analyses of the distribution of autoradiographic silver grains in the cerebellar cortex and dentate nucleus showed a general distribution of GABA receptors in the neuropil: molecular layer > granular layer > cerebellar nuclei > white matter. The highest binding of [(3)H]M occurred on the Purkinje cell somatic surface, in the basket axon formation surrounding the cell body and its axon initial segment, and somewhat less on basket and stellate cell somata. Neuroglial cells of the cortex have no [(3)H]M binding capacity; some glial cells in the cerebellar nuclei do. The role of glial cells in GABA uptake, metabolism, and GABA-receptor-mediated mechanisms remains to be clarified. The distribution of GABA receptors as indicated by [(3)H]M binding differs from the distribution of [(3)H]GABA uptake and GABA synthesizing and degradative sites.

Aminobutyrates↗

Recordings of extracellular glutamate and gamma-aminobutyric acid in the striatum of non-anesthetized rats. K(+)-stimulation, its Ca(2+)-dependence and lack of effects of drugs acting on dopamine receptors.

The extracellular concentrations of glutamate (GLU) or gamma-aminobutyric acid (GABA) in the striatum were determined in non-anesthetized, non-restrained rats using the microdialysis method, and the effects of some dopaminergic drugs were studied. Since a great part of these amino acids in the extracellular space is probably of origin not related to neurotransmission, the percentage of amino acids of neuronal origin was increased by stimulation with K+ added to the perfusion medium, and the Ca(2+)-dependence of K+ stimulated release was checked. This stimulation was performed twice in most of the experiments, under standard condition and after specific manipulations. K+ (100 mmol/l) produced pronounced increases in the overflow of GLU and even more of GABA. Omission of Ca2+ and addition of 20 mmol/l of Mg2+ in the medium significantly decreased the K(+)-stimulated overflow of GLU, but not of GABA. However, when in the whole perfusion procedure K+ was elevated and, initially, the medium was kept Ca(2+)-free, but contained 20 mmol/l of Mg2+, and subsequently was replaced by a medium containing Ca2+, but no Mg2+, then the shift to the second medium led to considerable increases in overflow both of GLU and GABA indicating a partial Ca(2+)-dependence of K(+)-stimulated overflow and suggesting at least a partial neuronal origin of the extracellular amino acids. In subsequent experiments, dopaminergic drugs were administered systemically before the second stimulation with K+. Apomorphine (2 mg/kg s.c.) had no effect on the K(+)-stimulated GABA overflow.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

[Gamma-aminobutyric acid metabolism in the rat brain after administration of nootropic agents].

N,N-bis-pyrrolidonomethyl-diaza - 18-crown-6 and piracetam, which are structural analogues of gamma-aminobutyric acid (GABA) and exhibit nootropic properties, affected the GABA metabolism, the content of total protein, DNA and RNA in rat brain after long-term administration at pharmacologically active doses of 100 mg/kg and 400 mg/kg, respectively. As compared with control values, content of GABA in rat brain was increased by 40% after administration of N,N-bis-pyrrolodonomethyl-diaza-18-crown-6 and by 28%--after treatment with piracetam. At the same time, activity of GABA transaminase was decreased by 49.4% and 39.8%, respectively, while the decarboxylase activity was unaltered.

4-Aminobutyrate Transaminase↗

Existence of gamma-aminobutyric acid and its biosynthetic and metabolic enzymes in rat salivary glands.

To obtain more insight into the physiological role of gamma-aminobutyric acid (GABA) in rat salivary glands, we measured the concentration of GABA and the activities of its biosynthetic and metabolic enzymes, glutamate decarboxylase (GAD) and GABA transaminase (GABA-T). The GABA concentrations in rat parotid and submandibular glands were 10.0 and 14.3 nmol/g weight, respectively, which were 0.6-0.8% of the levels in the brain (cerebellum and medulla oblongata), whereas glutamic acid (Glu) was abundant in the two glands. These GABA levels in the two glands were significantly decreased by administration of semicarbazide (200 mg/kg, i.p.), a GAD inhibitor, and increased by gabaculine (50 mg/kg, i.p.), a GABA-T inhibitor. The activities of both GAD and GABA-T were also detected in homogenates of the two salivary glands, but they were lower than those in the brain. However, kinetic analysis showed that the values of Michaelis constants for Glu and GABA in both enzyme reactions in these two glands were similar to those in the brain. These results indicate that GABA and its biosynthetic and metabolic enzymes are present in rat salivary glands as well as the brain.

4-Aminobutyrate Transaminase↗

Changes in high affinity sodium independent gamma-aminobutyric acid binding in cerebral cortex and hippocampus of the rat following electroshock.

Electroshock induced seizures in the rat enhanced high affinity specific Na+ independent binding of 3H-gamma aminobutyric acid (GABA) to frozen, Triton X-100 treated cerebral synaptic membranes 30 minutes after exposures to electroshock, although no change in 3H GABA binding was observed in similarly treated preparations from hippocampus. Scatchard analysis of the binding isotherms from cortical membranes indicated that the increase in 3H GABA binding at 30 minutes was due to a rapid increase (39%) in the number of available GABA receptor binding sites (Bmax) rather than an alteration in receptor affinity (KD). The number of binding sites returned to control values within 1 hour and remained so throughout the duration of this study.

Animals↗

Morphological characterization of marginal (lamina I) neurons immunoreactive for substance P, enkephalin, dynorphin and gamma-aminobutyric acid in the rat spinal cord.

Neurons of the rat spinal cord were immunostained for substance P, enkephalin and dynorphin in colchicine-treated animals, and for gamma-aminobutyric acid (GABA). Lamina I stained cells were classified in the four neuronal groups of our previous morphological classification of marginal cells (See Lima and Coimbra, 1986), according to their configuration in the three main anatomical planes. Most lamina I cells exhibiting substance P-immunoreactivity belonged in the group of flattened neurons. Most enkephalinergic cells were pyramidal neurons, while GABA-immunoreactive cells included all multipolar stained neurons and some fusiform neurons. Dynorphin-immunoreactive cells could be fusiform, pyramidal or flattened. The different neurochemical nature and supraspinal projection patterns are suggestive of functional specificity for each group. It is likely that each immunocytochemical subset in each cell group includes tract cells acting at their projection target and intrinsic neurons with local functional roles.

Animals↗

Brain gamma-aminobutyric acid measurement by proton double-quantum filtering with selective J rewinding.

An optimized single-shot proton double-quantum (DQ) filter for the quantification of gamma-aminobutyric acid (GABA) levels in human brain is reported. It is demonstrated that creation of DQ coherences following dual-resonance-selective refocusing gives a theoretical editing efficiency of 50% for the detection of the GABA resonance at 3.01 ppm. The sequence times are optimized with both numerical and experimental analyses of the editing performance, giving an experimental editing efficiency of 42%. It is acknowledged that homocarnosine is partially coedited, leading to a 20% contribution to the edited signal; however, macromolecule contamination is negligible in vivo under these experimental conditions. The GABA concentration in human prefrontal cortex is estimated to be 0.8 +/- 0.1 micromol/g (mean +/- SD, n = 6), with reference to the internal standard creatine at 9 micromol/g.

Adult↗

Differential blocking actions of 4'-ethynyl-4-n-propylbicycloorthobenzoate (EBOB) and gamma-hexachlorocyclohexane (gamma-HCH) on gamma-aminobutyric acid- and glutamate-induced responses of American cockroach neurons.

4'-Ethynyl-4-n-propylbicycloorthobenzoate (EBOB) has been employed extensively as a radioligand in binding assays to evaluate the pharmacology of gamma-aminobutyric acid (GABA)-gated Cl- channels (GABARs) of insects and mammals, and gamma-hexachlorocyclohexane (gamma-HCH) was used as an insecticide targeting insect GABARs. Since recent studies have shown that not only GABARs but also glutamate-gated chloride channels (GluCls) are blocked by picrotoxinin, dieldrin and fipronil, the actions of EBOB and gamma-HCH on native GABARs and GluCls of terminal abdominal ganglion neurons in American cockroach (Periplaneta americana) were tested using patch-clamp electrophysiology. A marked run-down of the GABA- and glutamate-induced responses of the cockroach neurons occurred, when a standard pipette solution was employed, but addition of pyruvate to the solution permitted stable recordings of these responses. With this solution, EBOB and gamma-HCH were found to block not only the GABA- but also glutamate-gated responses, with the actions augmented by repeated co-application with the agonists. It was also found that prolonged pre-application of EBOB and gamma-HCH prior to co-application with GABA and glutamate resulted in enhanced blocking actions, indicating resting-state actions of the blockers. The blocking actions of EBOB and gamma-HCH on the GABA- and glutamate-induced responses were compared by determining IC50 values under steady state condition. The IC50 values for the actions of EBOB on GABAR and GluCls differed less than those of gamma-HCH.

Animals↗

Release of gamma-aminobutyric acid from the visual cortex of young kittens.

Barbiturate-anaesthetized kittens of less than one month of age were used for the quantitative determination of the in vivo release of endogenous gamma-aminobutyric acid (GABA) from visual cortex by two methods: push-pull perfusion and cortical cup superfusion. Analysis by high-performance liquid chromatography (HPLC) demonstrated that marked elevations of GABA were elicited during electrical stimulation of cortex (inside the cup or adjacent to the cannulae) and were released into the artificial extracellular fluid perfused within the collecting cup or through the cannulae. The results provide additional support for the view that GABA-mediated neuronal inhibition in early ontogenetic stages of visual cortex is widespread and robust.

Aging↗

CSF cholecystokinin, gamma-aminobutyric acid and neuropeptide Y in pathological gamblers and healthy controls.

The sulphated cholecystokinin (CCK) octapeptide (CCK-8S), the CCK tetrapeptide (CCK-4), neuropeptide Y (NPY) and gamma-aminobutyric acid (GABA) were determined in cerebrospinal fluid (CSF) obtained from 11 pathological male gamblers and 11 healthy male controls. Compared with healthy controls, pathological male gamblers displayed higher concentrations of CCK-8S, CCK-4 and GABA (but not NPY). A gradient with decreasing concentrations from the first to the third 6-ml CSF fraction was found for CCK-8S, CCK-4 and NPY, but only in pathological gamblers. Disrupted gradients were found for GABA and for NPY in healthy controls. Given that CCK is a modulator of dopamine in the reward process, the increase in CCK-8S and CCK-4 is not unexpected. The high level of GABA in pathological gamblers is in conformity with a compensatory inhibitory action on noradrenergic neurons. The CSF gradient of CCK-8S and CCK-4 in pathological male gamblers (but not healthy controls) might indicate a difference in diurnal variation. The results obtained are in line with an altered CCK and GABA function in pathological gambling.

Adult↗

Stimulatory action of gamma-aminobutyric acid on catecholamine secretion from bovine adrenal chromaffin cells measured by a real-time monitoring system.

The present study was designed to evaluate the role of gamma-aminobutyric acid (GABA) in the secretory function of cultured chromaffin cells using the method of real-time monitoring. GABA evoked the secretion of catecholamines (CA) from adrenal chromaffin cells in a dose-dependent manner. Bicuculline 10(-5) M inhibited the stimulatory action of GABA. Diazepam 5 X 10(-6) and 2.5 X 10(-5) M facilitated the secretory response evoked by 7 X 10(-5) M GABA by 22% and 96%, respectively, which was antagonized by Ro 15-1788. This finding suggests that GABA-benzodiazepine receptor coupling can function in the secretion of CA from the adrenal chromaffin cells in a manner similar to that observed in the brain. GABA-evoked release of CA was reduced by 1 microM nifedipine to 16% of control, suggesting the involvement of voltage-sensitive Ca2+ channels in the mechanisms of the CA-releasing action of GABA in these cells. From these findings, the involvement of GABAergic mechanisms in the regulation of adrenal medullary function can be proposed.

Adrenal Glands↗

Laminar distribution of GABA (gamma-aminobutyric acid) in the dorsal lateral geniculate nucleus, Area 17 and Area 18 of the visual cortex, and the superior colliculus of the cat.

The laminar distribution of gamma-aminobutyric acid (GABA) was studied in certain structures of the visual system of the adult cat. A microassay method to measure GABA (10(-12) mol) was established using enzymatic cycling of NADP-NADPH. In the dorsal lateral geniculate nucleus, GABA concentration was highest in lamina A (average concentration 23 mmol/kg dry weight) and lowest in lamina C. In the visual cortex (Areas 17 and 18), the concentration of GABA was 10-12 mmol/kg dry weight in layers I-IV and 5-8 mmol/kg dry weight in layers V and VI. No significant difference was found in the GABA distribution in Areas 17 and 18. In the superior colliculus, the highest level of GABA was found in the upper part of the superficial gray layer (40 mmol/kg dry weight), whereas the deep layers contained GABA at a concentration of 23-28 mmol/kg dry weight. The results of the GABA distribution measurements revealed an orderly, layer-specific disposition of the neurotransmitter in the cat visual system. GABA may play an important role in the function of the visual system.

Animals↗

Anion selectivity of gamma-aminobutyric acid (GABA) 22,23-dihydroavermectin B1a (DHAVM)-induced conductance changes on locust muscle.

Input conductance was recorded from extensor tibia muscle fibres of the locust Schistocerca gregaria. gamma-Aminobutyric acid (GABA; 2.5 X 10(-5) M to 5 X 10(-3) M) and 22,23-dihydroavermectin B1a (DHAVM; 0.01 micrograms/ml, 1.2 X 10(-8) M to 1.0 microgram/ml, 1.2 X 10(-6) M) induced dose-dependent increases in chloride (Cl-) ion permeability on distal muscle fibres. Changing the anion content (Br-, or I- substituted for Cl-) of the saline perfusing the locust muscle fibres induced additional conductance and small hyperpolarizations of the membrane potential. The predominant anion permeability sequences for conductance increases induced by GABA and DHAVM were I- greater than Br- greater than Cl- (n = 5) and Cl- greater than Br- greater than I- (n = 12), respectively. These findings suggest that the anion channel activated by GABA has low selectivity. The irreversible increase in conductance induced by DHAVM appears to involve an ion channel with greater selectivity for Cl-. However, DHAVM-induced changes in filtering properties of a single type of Cl- channel are not precluded. This is consistent with DHAVM action not being dependent on GABA sensitivity of the locust muscle fibres.

Animals↗

The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation.

Exposure to high levels of manganese (Mn) results in a neurological disorder, termed manganism, which shares a similar phenotype to Parkinson's disease due to the involvement of the basal ganglia circuitry in both. The initial symptoms of manganism are likely due to the involvement of the globus pallidus, a region rich in gamma-aminobutyric acid (GABA) projections, while those of Parkinson's disease are related to the degeneration of the substantia nigra, a dopaminergic nucleus. Additionally, it is known that glutamate regulation is affected by increases in brain Mn levels. As Mn predominantly accumulates in the basal ganglia, it potentially could affect the regulation and interactions of all three neurotransmitters. This review will focus on the circuitry of these neurotransmitters within the basal ganglia and address potential sites for, as well as the temporal relationship, between Mn exposure and changes in the levels of these neurotransmitters. While most research has focused on perturbations in the dopaminergic system, there is evidence to support that early consequences of manganism also include disturbances in GABA regulation as well as glutamatergic-related excitotoxicity. Finally, we suggest that current research focus on the interdependence of these basal ganglial neurochemicals, with a greater emphasis on the GABAergic and glutamatergic systems.

Animals↗

Pre-natal and post-natal effects of alcohol in the rat--II. Changes in gamma-aminobutyric acid concentration and adenosine triphosphatase activity in the brain.

The effects of chronic alcohol administration during the pre-natal and/or post-natal period on concentration of gamma aminobutyric acid (GABA) in the amygdaloid cortex and striatum and on activities of Na+, K+- and Mg2+ -activated adenosine triphosphatases (ATPases) in the mid-brain and hippocampus were studied. There was a small decrease in the GABA content of both brain regions in those offspring that had received alcohol immediately before, but not in those that were free of the drug at chi the time of death. This suggests that the changes in GABA concentration are due to a direct pharmacological effect of ethanol. A decrease also occurred in the activity of the Mg2+ -activated ATPase in those offspring exposed to alcohol during the period of weaning. This effect could not be attributed to a direct action of the drug, but may be indicative of a longer-term influence of ethanol on membrane transport processes. The increase in the activity of the Na+, K+ -activated ATPase in the mid-brain of rats that were exposed to the drug pre-natally and post-natally and following weaning is probably due to a direct effect of the drug.

Adenosine Triphosphatases↗

Triethyllead inhibits gamma-aminobutyric acid binding to uptake sites in synaptosomal membranes.

Triethyllead (TEL), the active metabolite of tetraethyllead, was shown previously to inhibit selectively high-affinity Na+-dependent uptake of gamma-aminobutyric acid (GABA) into cerebrocortical synaptosomes. Such inhibition was not related to the Na+ gradient, Na+,K+-ATPase activity, [Cl-], or energy charge. We report here that TEL inhibits GABA binding to the presynaptic transporter involved in Na+-dependent uptake. Scatchard plot analysis of Na+-dependent [3H]GABA binding to a highly purified synaptic plasma membrane preparation revealed that 25 microM TEL reduced the Bmax by 44%, leaving the KD unchanged. This binding was reversible and predominantly involved membrane uptake sites, as characterized by pharmacological specificity to GABA ligands. Approximately 85% of specific GABA binding was considered membrane uptake site binding, as indicated by sensitivity to nipecotic acid and diaminobutyric acid, with relative insensitivity to muscimol, bicuculline methiodide, baclofen, and beta-alanine. With respect to previous data, these finding suggest that TEL inhibits Na+-sensitive high-affinity GABA uptake by interfering with GABA binding to its presynaptic transporter.

Animals↗

Localisation of ionotropic glutamate receptor subunits, and gamma-aminobutyric acid (GABA) in the monkey amygdala--a double immunolabelling and electron microscopic study.

The distribution of ionotropic glutamate receptor subunits GluR1 and NMDAR1, and the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) was studied by immunocytochemistry, in the monkey amygdala. The basal and lateral nuclei contained a higher density of GluR1-positive neurons than the corticomedial and central groups of nuclei, and the accessory basal nucleus. A higher density of NMDAR1 immunopositive cell bodies was also present in the lateral nucleus, compared to the other nuclei of the amygdala. Large multipolar or fusiform projection neurons, and not small local circuit neurons were GluR1 or NMDAR1-positive, and less than 0.5% of the GluR1-positive cells were double labelled for GABA. In contrast, almost all GluR1-positive neurons were also labelled for NMDAR1 in double labelled sections and vice versa. Electron microscopy also showed that GluR1- and NMDAR1-positive cells had distinctive ultrastructural features, compared with GABAergic cells, ant that there was very rare colocalisation, between GABA, and GluR1 or NMDAR1-positive cell bodies or dendrites. It is likely that not all projection neurons were GluR1 or NMDAR1-positive, however, since GluR1 or NMDAR1-positive neurons were only 2-3 times as common as GABAergic cells, whereas it has been estimated that projection neurons outnumber GABAergic local circuit neurons by 4 to 1 (McDONALD and AUGUSTINE, 1993; PITKANEN and AMARAL, 1994).

Amygdala↗

Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5'-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin.

Gamma-aminobutyric acid aminotransferase (GABA-AT) is a pyridoxal 5'-phosphate-dependent enzyme responsible for the degradation of the inhibitory neurotransmitter GABA. GABA-AT is a validated target for antiepilepsy drugs because its selective inhibition raises GABA concentrations in brain. The antiepilepsy drug, gamma-vinyl-GABA (vigabatrin) has been investigated in the past by various biochemical methods and resulted in several proposals for its mechanisms of inactivation. In this study we solved and compared the crystal structures of pig liver GABA-AT in its native form (to 2.3-A resolution) and in complex with vigabatrin as well as with the close analogue gamma-ethynyl-GABA (to 2.3 and 2.8 A, respectively). Both inactivators form a covalent ternary adduct with the active site Lys-329 and the pyridoxal 5'-phosphate (PLP) cofactor. The crystal structures provide direct support for specific inactivation mechanisms proposed earlier on the basis of radio-labeling experiments. The reactivity of GABA-AT crystals with the two GABA analogues was also investigated by polarized absorption microspectrophotometry. The spectral data are discussed in relation to the proposed mechanism. Intriguingly, all three structures revealed a [2Fe-2S] cluster of yet unknown function at the center of the dimeric molecule in the vicinity of the PLP cofactors.

4-Aminobutyrate Transaminase↗